Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-12-15 4:48 pm Purchase |
2022-07-25 | 13D | Immune Therapeutics, Inc. IMUN |
Salomonsky Henry Louis | 12,168,900 14.700% |
12,168,900![]() (New Position) |
Filing History |
2021-06-07 07:06 am Purchase |
2021-05-28 | 13D | Immune Therapeutics, Inc. IMUN |
Griffin Noreen | 59,877 12.400% |
59,877![]() (New Position) |
Filing History |
2020-06-25 8:26 pm Unchanged |
2020-06-25 | 13G | Immune Therapeutics, Inc. IMUN |
Ahmetaj Erjon | 22 4.880% |
0 (Unchanged) |
Filing History |
2020-05-18 6:10 pm Sale |
2020-05-18 | 13G | Immune Therapeutics, Inc. IMUN |
Iliad Research & Trading, L.P. | 46 9.990% |
-45,467![]() (-99.90%) |
Filing History |